Learn more

MICROGENESYS INC

Overview
  • Total Patents
    94
About

MICROGENESYS INC has a total of 94 patent applications. Its first patent ever was published in 1986. It filed its patents most often in Australia, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are SMITH GALE, CODA BIOTHERAPEUTICS INC and ADVERUM BIOTECHNOLOGIES INC.

Patent filings per year

Chart showing MICROGENESYS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Volvovitz Franklin 56
#2 Smith Gale E 54
#3 Cochran Mark A 40
#4 Franklin Volvovitz 10
#5 Gale E Smith 6
#6 Mark A Cochran 4
#7 Smith Gale 3
#8 Knell John D 2
#9 Debartolomeis James 2
#10 Hackett Craig S 2

Latest patents

Publication Filing date Title
HU211505A9 Vaccine composition for the treatment of hiv infections
AU2517895A Hiv polyprotein immunogens
AU2517995A Immunogenic carcinoembryonic antigen and methods of use and production
LV10497A Process for the production of a vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type i
LV10495A Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells
LV10496A Polypeptide derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells
LV10492A Vaccine and treatment method for human immunodeficiency virus
HRP921484A2 Vaccine and treatment method of human immunodeficiency virus infection
SI9200420A Vaccine and treatment method for human immunodeficiency virus
BR9205290A Vacine and method for treating human immunodeficiency virus infection
IL102092D0 Use of recombinant hiv envelope protein in medicament for treating hiv and therapeutic composition containing the agglomerated protein
WO9102819A1 Recombinant japanese encephalitis molecules and methods of use therefor
IL93599D0 Kit and/or composition for the prevention or treatment of aids
CA2003300A1 Skin test and test kit for aids
AU2992489A Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
IL89118D0 Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
IL85149D0 Hiv gp160 aids virus envelope protein-containing substrates and methods for detection of aids antibody thereby
RO100380B1 Method for inducing aids virus coat protein production
RO99208B1 PROCESS FOR PRODUCING THE HEPATITIS B SURFACE ANTIGEN (HBsAg) AND THE VACCINIA VIRUS GROWTH FACTOR (VGF)
IE863325L Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom